Introduction
Drug Utilization Evaluation (DUE) studies are designed to evaluate drug usage appropriateness. 1 DUE is a structured process to analyze the pattern of drug administration in various practice settings, including hospitals in relation to guidelines or predetermined standards. Considerable therapeutic effects of antibiotics and the emergence of resistance make antibiotics very valuable worldwide drugs so appropriate use of them is necessary. 2 Vancomycin is a potent antibiotic with a definite indications and has importent role in the management of infections in patients who are recognized to have resistance to other intravenous and oral antibiotics or in patients who have allergy to beta-lactam antibiotics. Vancomycin is usually administred with slow intravenous infusion and has a beneficial therapeutic effect at trough Concentrations between 15-20 mg/L for treatment of infections caused by gram-positive pathogens, such as staphylococcus, streptococcus pyogenes, betalactamase producing streptococcus, streptococcus pneumonia, enterococci and clostridiums. Vancomycin acts by the inhibition of bacterial cell wall development and blocks it in an earlier stage in comparison to beta-lactam antibiotics. [3] [4] [5] In drug resistance settings, vancomycin is considered an alternative to other antibiotics such as penicillin and methicillin until 2002 but nowadays, as a result of
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inappropriate use, resistance to vancomycin is reported high, worldwide. Irrational use of vancomycin may result in increased morbidity or mortality due to toxicity and the emergence of resistant organisms and also impose additional costs. 6, 7 Hence, it is necessary to do DUE programs for this drug. Accurate and constant studies should be done to inform clinicians from inappropriate and illogical use of vancomycin and help them to find out a way to use and prescribe this valuable drug in a logical and rational pattern. In this study, a concurrent, drug utilization evaluation program was conducted in one of the educational Hospitals in Tabriz University of Medical Sciences to assess the pattern of vancomycin usage and prescription and its concordance with international standard treatment guidelines.
Materials and Methods
The use of vancomycin was evaluated in a crosssectional and concurrent study from October 2011 until June 2012. The study was conducted in Shohada Hospital, which is one of the teaching hospitals of Tabriz University of Medical Sciences and the major trauma center in Tabriz. Vancomycin administration was assessed according to CDC and ASHP guidelines. 8, 9 Predesigned data collection was implemented in this study. Information collected from medical records, patient's history, medical orders, nursing reports and the experimental results available in the patient's records. Parameters which were recorded include: duration of vancomycin use, history of drug allergy, first and final diagnoses, type of administration, monitoring necessity, dosing regimen, microbiological culture/sensitivity testing and occurrence of adverse drug reaction. Indications for Vancomycin use according to CDC and ASHP guidelines are presented in Table 1 and 2, respectively. Information was collected and Data were analyzed using SPSS16 software. 
Results
During the study period, 75 cases were been evaluated from all of the hospital wards. The median age of patients was 46.65±20.04 years (mean ± SD). The youngest patient was 9 years old and the oldest one was 104 years. The median time of vancomycin use in the study population was 9.35±5.70 days. Maximum duration of vancomycin use was seen in a patient with pneumonia for 25 days and the minimum duration was for a patient with cellulite diagnosis for 1 day. In this study, 34 patients (45.3%) were female and 41 patients were male (54.7%). Since this study was conducted in the referral center for trauma, most of the patients received vancomycin had been hospitalized for trauma problems (28 cases), other reasons for hospitalization and vancomycin use were: cerebrospinal disease (15 cases), Postoperative infections (14 cases), osteomyelitis (7cases), factitious and cellulitis (4 cases), septic arthritis (3 cases), spinal stenosis (2 cases) and osteoarthritis (2 cases). The most frequent indication for vancomycin use, during 6 months of study period, appeared to be for prophylaxis purposes (24 patients) ( In our study, Vancomycin frequently was administred for prophylaxis purposes before and after surgery (32%). Among those who received vancomycin for prophylaxis, only 16.29% of cases, had correct indication for receiving vancomycin. Also In a similar study Misan and colleagues, evaluated 59 patients who received vancomycin in a teaching hospital for 5 month. they reported that in the first phase of their study, 97% of patients who received vancomycin for prophylaxis purposes, were classified as inappropriate use. 13 Since the type of surgery and patients with risk factors for MRSA infections not mentioned in that study we can not judge about the appropriateness of vancomycin prescription.
Patients with the following conditions are considered to be at high risk of MRSA infection: Patients who hospitalized and recieve long-term care facilities for a long time, patients undergo hemodialysis, Receiveing cancer treatment or medications that compromise their immune systems, Inject illegal drugs, Had surgery in the past year, People who have tattoos, Members of the millenarians, athletes and other people who may share items such as towels or razors. 14, 15 In our study, the patients who had received inappropriate vancomycin prophylaxis were for pre and post orthopedic surgery and Neurosurgery. In accordance to CDC guidelines for using vancomycin as a prophylaxis before and after surgery, microbiology laboratory should report recurrent staphylococcus aurous infection after surgery or the patient recognized to have a risk factor for MRSA infection or the patient has allergy to β-lactams. In the absence of mentioned conditions cefazolin is offered for prophylaxis. 10 , It is essential to promote practical guidelines about utilizing culture and sensitivity testing when considering the use of important antibiotics such as vancomycin. Also educational programs for health care professionals regarding rational use of antibiotics can be helpful in improving antimicrobial medications utilization and monitoring.
Conclusion
In conclusion, the following hints are recommended to achieve rational use of vancomycin in our hospitals: 1. Accomplishment the vancomycin standard treatment guideline modified according to local resistance pattern in hospitals 2. Conducting antibiotic usage review studies 3. Sending periodically feedbacks to physicians and nurses involved mostly in vancomycin administration 4. Setting pharmaceutical and therapeutic infection control committees in hospitals to discuss issues regarding antibiotic usage patterns and approaches 5. Reevaluating laboratory tests and processes related to infection control 6. Conducting educational programs for health care professionals regarding rational use of antimicrobial medications.
